S&P 500   4,333.57 (+0.16%)
DOW   34,040.63 (-0.35%)
QQQ   339.93 (-0.34%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,333.57 (+0.16%)
DOW   34,040.63 (-0.35%)
QQQ   339.93 (-0.34%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,333.57 (+0.16%)
DOW   34,040.63 (-0.35%)
QQQ   339.93 (-0.34%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,333.57 (+0.16%)
DOW   34,040.63 (-0.35%)
QQQ   339.93 (-0.34%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
NASDAQ:INVO

INVO Bioscience News Headlines

$2.67
-0.13 (-4.64%)
(As of 01/28/2022 10:26 AM ET)
Add
Compare
Today's Range
$2.67
$2.75
50-Day Range
$2.80
$3.90
52-Week Range
$2.60
$12.30
Volume
240 shs
Average Volume
48,437 shs
Market Capitalization
$31.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.95
Get INVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

INVO Bioscience Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INVO
News Sentiment

0.50

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INVO Articles
This Week

1

1

INVO Articles
Average Week



INVO Bioscience (NASDAQ:INVO) News Headlines Today

SourceHeadline
ca.finance.yahoo.com logoLearning Management System (LMS) Global Market Report 2022
ca.finance.yahoo.com - January 26 at 4:11 AM
MarketBeat logoShort Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Decreases By 26.1%
americanbankingnews.com - January 19 at 8:30 PM
MarketBeat logoINVO Bioscience (NASDAQ:INVO) Coverage Initiated by Analysts at Maxim Group
americanbankingnews.com - January 19 at 9:08 AM
finance.yahoo.com logoINVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization
finance.yahoo.com - December 16 at 10:39 AM
benzinga.com logoINVO Bioscience To Participate In Lytham Partners Winter 2021 Investor Conference
benzinga.com - December 10 at 2:47 PM
finance.yahoo.com logoINVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand
finance.yahoo.com - December 1 at 10:33 AM
finance.yahoo.com logoINVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
finance.yahoo.com - November 15 at 7:13 PM
markets.businessinsider.com logoHere's what to expect from INVO Bioscience's earnings
markets.businessinsider.com - November 14 at 1:16 PM
finance.yahoo.com logoINVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
finance.yahoo.com - November 9 at 7:28 PM
msn.com logoWill Invo BioScience Inc. (INVO) Report Negative Q3 Earnings? What You Should Know
msn.com - November 8 at 7:15 PM
finance.yahoo.com logoINVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo
finance.yahoo.com - October 20 at 1:15 PM
finance.yahoo.com logoINVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021
finance.yahoo.com - October 14 at 10:36 AM
benzinga.com logoINVO Bioscience Earnings Perspective: Return On Capital Employed
benzinga.com - October 1 at 3:39 PM
finance.yahoo.com logoINVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - October 1 at 9:50 AM
finance.yahoo.com logoINVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada
finance.yahoo.com - September 9 at 8:27 AM
finance.yahoo.com logoINVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta
finance.yahoo.com - September 7 at 11:18 AM
finance.yahoo.com logoGlobal $28.3 Billion Fertility Services Markets to 2030: Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, Frozen Donor
finance.yahoo.com - August 19 at 9:08 AM
benzinga.com logoImpact Of COVID-19 On The Global Fertility Services Market By The Business Research Company
benzinga.com - August 19 at 9:08 AM
nasdaq.com logoInvo BioScience Inc. (INVO) Reports Q2 Loss, Lags Revenue Estimates
nasdaq.com - August 16 at 8:09 PM
bizjournals.com logoINVO Center opening in metro Birmingham
bizjournals.com - August 6 at 12:56 PM
finance.yahoo.com logoInvo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 5 at 6:02 PM
finance.yahoo.com logoINVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama
finance.yahoo.com - August 2 at 5:24 PM
finance.yahoo.com logoINVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration
finance.yahoo.com - July 14 at 8:50 AM
finance.yahoo.com logoINVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta
finance.yahoo.com - June 30 at 10:09 AM
msn.com logoNew Strong Sell Stocks for May 21st
msn.com - May 21 at 1:41 PM
finance.yahoo.com logoINVO BioScience, Inc. to Host Earnings Call
finance.yahoo.com - May 17 at 2:55 PM
finance.yahoo.com logoINVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
finance.yahoo.com - May 11 at 6:57 PM
finance.yahoo.com logoINVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
finance.yahoo.com - April 26 at 4:39 PM
finance.yahoo.com logoINVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021
finance.yahoo.com - March 26 at 9:27 AM
marketwatch.com logoThinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?
marketwatch.com - March 16 at 5:54 PM
bizjournals.com logoINVO Bioscience opening fertility clinic in Birmingham
bizjournals.com - March 16 at 5:54 PM
finance.yahoo.com logoINVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United States
finance.yahoo.com - March 15 at 9:04 AM
finance.yahoo.com logoIs INVO Bioscience Stock a Buy Right Now? This Is What You Need to Know
finance.yahoo.com - March 11 at 8:33 PM
finance.yahoo.com logoINVO Bioscience to Participate in the 33rd Annual Roth Conference
finance.yahoo.com - March 11 at 10:32 AM
finance.yahoo.com logoInvo Bioscience Stock Rallies After Amended Agreement Expands Company-Owned Clinics In US
finance.yahoo.com - March 10 at 7:58 AM
msn.com logoWhy INVO Bioscience Shares Jumped 202% Today
msn.com - March 10 at 12:39 AM
markets.businessinsider.com logoMid-Afternoon Market Update: Nasdaq Surges Over 500 Points; INVO Bioscience Shares Spike Higher
markets.businessinsider.com - March 9 at 2:51 PM
finance.yahoo.com logoMeme Stock Revival Drives Millions of Trades in Tiny Stocks
finance.yahoo.com - March 9 at 2:38 PM
markets.businessinsider.com logoINVO Bioscience Amends U.S. Commercialization Agreement
markets.businessinsider.com - March 8 at 6:29 PM
finance.yahoo.com logoINVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico
finance.yahoo.com - March 1 at 9:32 AM
markets.businessinsider.com logoWorldwide Infertility Treatment Devices and Equipment Industry to 2027 - Growing Number of Product Launches and Developments Presents Opportunities
markets.businessinsider.com - February 27 at 12:16 AM
benzinga.com logoFertility Market Size to Hit Around US$ 47.9 Billion by 2030
benzinga.com - February 10 at 5:29 PM
finance.yahoo.com logoINVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.
finance.yahoo.com - January 15 at 8:38 AM
marketwatch.com logoGlobal Preimplantation Genetic Diagnostics (PGD) Market 2020 Industry Analysis, Key Drivers, Business Strategy, Opportunities and Forecast to 2025
marketwatch.com - January 11 at 3:18 AM
finance.yahoo.com logoINVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility Industry
finance.yahoo.com - November 18 at 11:43 AM
finance.yahoo.com logoINVO Bioscience Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 16 at 7:54 PM
seekingalpha.com logoInvo Bioscience prices follow-on offering at $3.20, lists on Nasdaq
seekingalpha.com - November 13 at 8:09 AM
finance.yahoo.com logoINVO Bioscience Reports Second Quarter 2020 Financial Results
finance.yahoo.com - October 30 at 1:07 AM
Get INVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.